Cargando…

Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool

BACKGROUND: Preclinical research suggests that cannabidiol (CBD) may have therapeutic potential in pathological anxiety. Dosing guidelines to inform future human studies are however lacking. AIM: We aimed to predict the therapeutic window for anxiety-reducing effects of CBD in humans based on precli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwee, Caroline MB, van Gerven, Joop MA, Bongaerts, Fleur LP, Cath, Danielle C, Jacobs, Gabriël, Baas, Johanna MP, Groenink, Lucianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716490/ https://www.ncbi.nlm.nih.gov/pubmed/36239014 http://dx.doi.org/10.1177/02698811221124792

Ejemplares similares

Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial
por: van der Flier, Febe E., et al.
Publicado: (2019)

High Current Anxiety Symptoms, But Not a Past Anxiety Disorder Diagnosis, are Associated with Impaired Fear Extinction
por: Duits, Puck, et al.
Publicado: (2016)

Human Fear Acquisition Deficits in Relation to Genetic Variants of the Corticotropin Releasing Hormone Receptor 1 and the Serotonin Transporter
por: Heitland, Ivo, et al.
Publicado: (2013)

Cannabidiol-Decorated Berberine-Loaded Microemulsions Improve IBS-D Therapy Through Ketogenic Diet-Induced Cannabidiol Receptors Overexpression
por: Fan, Xinyu, et al.
Publicado: (2023)

Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
por: Calapai, Gioacchino, et al.
Publicado: (2019)

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
por: Melas, Philippe A., et al.
Publicado: (2021)

CANNABIDIOL- PROVOKES OR TREATS ANXIETY DISORDERS?
por: Arshad, H., et al.
Publicado: (2023)

Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
por: Zavala-Tecuapetla, Cecilia, et al.
Publicado: (2022)

Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety
por: Fliegel, Danielle K., et al.
Publicado: (2022)

Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
por: Anderson, Lyndsey L., et al.
Publicado: (2019)

Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study
por: Razavi, Yasaman, et al.
Publicado: (2021)

Anxiety and IBS revisited: ten years later
por: POPA, STEFAN-LUCIAN, et al.
Publicado: (2015)

Effect of Cannabidiol on the Long-Term Toxicity and Lifespan in the Preclinical Model Caenorhabditis elegans
por: Land, M. Hunter, et al.
Publicado: (2021)

Cannabidiol as a personalized treatment for anxiety: clinical cases in Mexico
por: Ortiz Rios, Flor Cristina, et al.
Publicado: (2022)

Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies
por: Hart, Elvin't, et al.
Publicado: (2022)

Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders
por: Jurkus, Regimantas, et al.
Publicado: (2016)

Anxiolytic Effects of Repeated Cannabidiol Treatment in Teenagers With Social Anxiety Disorders
por: Masataka, Nobuo
Publicado: (2019)

Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression
por: Laczkovics, Clarissa, et al.
Publicado: (2020)

5-HT(1A) receptor blockade reverses GABA(A) receptor α(3) subunit-mediated anxiolytic effects on stress-induced hyperthermia
por: Vinkers, Christiaan H., et al.
Publicado: (2010)

Effect of MBSR on Anxiety and Depression of Patients with Gastrointestinal Disorder (IBS-M)
por: Akhouri, Deoshree, et al.
Publicado: (2022)

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
por: García-Gutiérrez, María S., et al.
Publicado: (2020)

The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study
por: Bloomfield, Michael A. P., et al.
Publicado: (2022)

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022)

A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas
por: Hidalgo, Manuel, et al.
Publicado: (2022)

Cannabidiol Modulates the Motivational and Anxiety-Like Effects of 3,4-Methylenedioxypyrovalerone (MDPV) in Mice
por: Alegre-Zurano, Laia, et al.
Publicado: (2021)

Serotonin(1A) receptor deletion does not interact with maternal separation-induced increases in startle reactivity and prepulse inhibition deficits
por: Groenink, Lucianne, et al.
Publicado: (2010)

Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer
por: Tomko, Andrea, et al.
Publicado: (2019)

Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
por: Abbotts, Kieran Shay Struebin, et al.
Publicado: (2022)

Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim
por: Johnson, Erin, et al.
Publicado: (2022)

A Measure of Suffering in relation to Anxiety and Quality of Life in IBS Patients: Preliminary Results
por: Pletikosić Tončić, Sanda, et al.
Publicado: (2017)

Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer’s disease mouse model
por: Chesworth, Rose, et al.
Publicado: (2022)

Cannabidiol for Treatment of Childhood Epilepsy–A Cross-Sectional Survey
por: Klotz, Kerstin A., et al.
Publicado: (2018)

Modelling of IBS
por: Zampetakis, Michail
Publicado: (2019)

Cannabidiol in Parkinson’s disease
por: Rieder, Carlos R.
Publicado: (2020)

The antimicrobial potential of cannabidiol
por: Blaskovich, Mark A. T., et al.
Publicado: (2021)

Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)

The Polypharmacological Effects of Cannabidiol
por: Castillo-Arellano, Jorge, et al.
Publicado: (2023)

The effect of SSRIs on fear learning: a systematic review and meta-analysis
por: Heesbeen, Elise J., et al.
Publicado: (2023)

Pharmacological modulation of conditioned fear in the fear-potentiated startle test: a systematic review and meta-analysis of animal studies
por: Groenink, Lucianne, et al.
Publicado: (2023)

Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy
por: Klotz, Kerstin A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_stvt3m1v9mgpuul04qo7ae47o6